Oppenheimer Asset Management Inc. Quidel Ortho Corp Transaction History

Oppenheimer Asset Management Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 13, 2024	SELL	$58.16 - $75.44 $80,260 - $104,107	-1,380 Reduced 13.8%	8,622 $635,000
Q3 2023 Nov 07, 2023	BUY	$70.9 - $88.63 $123,224 - $154,038	1,738 Added 21.03%	10,002 $730,000
Q2 2023 Aug 02, 2023	BUY	$81.09 - $94.16 $48,167 - $55,931	594 Added 7.74%	8,264 $684,000
Q1 2023 May 10, 2023	BUY	$82.98 - $91.46 $92,937 - $102,435	1,120 Added 17.1%	7,670 $683,000
Q4 2022 Feb 06, 2023	BUY	$66.93 - $97.5 $79,780 - $116,220	1,192 Added 22.25%	6,550 $561,000
Q3 2022 Nov 14, 2022	BUY	$69.86 - $107.63 $216,775 - $333,975	3,103 Added 137.61%	5,358 $383,000
Q2 2022 Aug 08, 2022	BUY	$89.06 - $117.64 $200,830 - $265,278	2,255 New	2,255 $219,000

293

67.9M

337K

134K

Ticker QDEL
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 66,952,900
Market Cap $2.74B
Description
QuidelOrtho Corporation focuses on the development and manufacture of diagnostic testing technologies across the continuum of healthcare testing needs. The company operates through Labs, Transfusion Medicine, Point-of-Care, and Molecular Diagnostics business units. The Labs business unit provides clinical chemistry laboratory instruments and tes...

Get notified when there are updates to the investment portfolio of Oppenheimer Asset Management Inc., based on Form 13F filings with the SEC.

Stay updated on Oppenheimer Asset Management Inc. with notifications on news.